uncovr

Alle Regionen

Alle Regionen Österreich Deutschland International

GlaxoSmithKline - GSK (UK) - Pressemeldungen

Alle Meldungen

21.10

GlaxoSmithKline - GSK (UK) GSK (UK)

GSK and Cambridge University announce new five-year collaboration in kidney and respiratory disease

Issued: London, UK For media and investors only Download (PDF, 128.8KB) The Cambridge-GSK Translational Immunology Collaboration (CG-TIC) brings together GSK’s expertise in the science of the immune system, AI and clinical development with...

Zur Pressemeldung auf www.gsk.com
16.10

GlaxoSmithKline - GSK (UK) GSK (UK)

ViiV Healthcare shows more than 99% effectiveness in real-world studies for Apretude (cabotegravir long-acting), the only approved long-acting HIV PrEP, in data presented at IDWeek 2024

Issued: London, UK For media and investors only Download (PDF, 271.8KB) Studies from OPERA and Trio cohorts provide further real-world evidence supporting CAB LA for PrEP’s high effectiveness and adherence in preventing HIV...

Zur Pressemeldung auf www.gsk.com
16.10

GlaxoSmithKline - GSK (UK) GSK (UK)

Gepotidacin accepted for priority review by US FDA for treatment of uncomplicated urinary tract infections in female adults and adolescents

Issued: London, UK For media and investors only Download (PDF, 206.3KB) Application supported by positive results from pivotal phase III EAGLE-2 and EAGLE-3 trials 26 March 2025 assigned as action date for FDA decision Gepotidacin could be the...

Zur Pressemeldung auf www.gsk.com
14.10

GlaxoSmithKline - GSK (UK) GSK (UK)

GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps

Issued: London, UK For media and investors only Download (PDF, 199.1KB) Primary endpoints met with statistically significant reduction in nasal polyp size and nasal obstruction versus placebo plus standard of care, at 52 weeks Depemokimab is an...

Zur Pressemeldung auf www.gsk.com
10.10

GlaxoSmithKline - GSK (UK) GSK (UK)

GSK and ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024

Issued: London, UK For media and investors only Download (PDF, 314.0KB) 60 abstracts to be presented across broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious disease New data to be shared on GSK’s RSV...

Zur Pressemeldung auf www.gsk.com
09.10

GlaxoSmithKline - GSK (UK) GSK (UK)

Statement: Zantac (ranitidine) litigation – settlement agreements reached

Issued: London, UK For media and investors only Download (PDF, 130.6KB) GSK to resolve 93% (approximately 80,000 cases) of U.S. state court Zantac product liability cases for up to $2.2 billion Separate settlement of qui tam complaint for $70...

Zur Pressemeldung auf www.gsk.com
08.10

GlaxoSmithKline - GSK (UK) GSK (UK)

GSK presents positive data for Arexvy, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV seasons

Issued: London, UK For media and investors only Download (PDF, 175.4KB) GSK’s RSV vaccine is the only RSV vaccine with efficacy and safety data available through 3 full seasons, including in people at increased risk Safety and reactogenicity...

Zur Pressemeldung auf www.gsk.com
07.10

GlaxoSmithKline - GSK (UK) GSK (UK)

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries

Issued: London, UK For media and investors only Download (PDF, 99.2KB) At least two million doses of long-acting cabotegravir for PrEP to be made available in 2025-2026 to meet growing demand where HIV burden and unmet need are greatest Strong...

Zur Pressemeldung auf www.gsk.com
24.09

GlaxoSmithKline - GSK (UK) GSK (UK)

GSK’s Menveo meningococcal vaccine in new single-vial, fully liquid presentation receives positive European CHMP opinion

Issued: London, UK For media and investors only Download (PDF, 176.5KB) If approved, the fully liquid presentation will offer healthcare providers an option that does not require reconstitution of Menveo (MenACWY vaccine) before use Marketing...

Zur Pressemeldung auf www.gsk.com
18.09

GlaxoSmithKline - GSK (UK) GSK (UK)

Statement: Zantac (ranitidine) litigation – Russell and Hughes cases

For media and investors only Issued: London, UK Download (PDF, 138.1KB) GSK plc (LSE/NYSE: GSK) today confirmed it has reached two confidential settlements in cases filed in California State Court with Mr. John Russell, resolving his bladder...

Zur Pressemeldung auf www.gsk.com

Wem folgen?

KTM
Folgen
Google
Folgen
ProSiebenSat.1 PULS 4
Folgen

Mehr anzeigen

Trends

Allerheiligen
Folgen
iphone
Folgen
ChatGPT
Folgen
Smart Home
Folgen
Halloween
Folgen
Energieeffizienz
Folgen
Digitale Transformation
Folgen

Mehr anzeigen

uncovr pure news - Die neue Art Presseinhalte zu recherchieren. Mehr Info